|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 148.22 USD | +0.26% |
|
+0.75% | +20.76% |
| 01:20pm | The Year the Easy Narrative Broke |  |
| 06:03am | South Africa seeks local production of Gilead's HIV prevention drug | RE |
| Capitalization | 184B 158B 144B 138B 251B 16,963B 261B 1,687B 675B 8,089B 691B 676B 28,892B | P/E ratio 2026 * |
20.5x | P/E ratio 2027 * | 17.8x |
|---|---|---|---|---|---|
| Enterprise value | 189B 162B 147B 141B 258B 17,388B 267B 1,729B 692B 8,292B 708B 693B 29,616B | EV / Sales 2026 * |
6.25x | EV / Sales 2027 * | 5.65x |
| Free-Float |
99.9% | Yield 2026 * |
2.2% | Yield 2027 * | 2.43% |
Last Transcript: Gilead Sciences, Inc.
| 1 day | -1.12% | ||
| 1 week | +0.75% | ||
| Current month | -0.49% | ||
| 1 month | +1.36% | ||
| 3 months | +20.88% | ||
| 6 months | +31.44% | ||
| Current year | +20.76% |
| 1 week | 143.37 |  | 150.77 |
| 1 month | 143.09 | | 157.29 |
| Current year | 116.88 | | 157.29 |
| 1 year | 93.37 | | 157.29 |
| 3 years | 62.07 | | 157.29 |
| 5 years | 57.16 | | 157.29 |
| 10 years | 56.56 | | 157.29 |
| Manager | Title | Age | Since |
|---|---|---|---|
Daniel O'Day
CEO | Chief Executive Officer | 60 | 28/02/2019 |
Andrew Dickinson
DFI | Director of Finance/CFO | 56 | 31/10/2019 |
Dietmar Berger
CTO | Chief Tech/Sci/R&D Officer | 64 | 01/01/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
Kelly Kramer
BRD | Director/Board Member | 58 | 18/08/2016 |
| Director/Board Member | 73 | 31/12/2017 | |
| Director/Board Member | 72 | 08/05/2018 |
| Name | Varia. Jan 1. | Weight | AuM | |
|---|---|---|---|---|
 | -1.88% | 13.99% | 253 M€ |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +0.26% | +0.75% | +29.18% | +82.83% | 184B | |
| -0.41% | -2.46% | +10.15% | +215.16% | 897B | |
| -0.59% | +0.05% | +48.29% | +59.27% | 591B | |
| +1.00% | +4.09% | +13.68% | +51.35% | 418B | |
| -1.11% | -2.26% | +17.22% | +31.29% | 368B | |
| -0.15% | -0.17% | +25.05% | +40.42% | 313B | |
| -1.10% | -1.14% | +26.64% | +59.86% | 312B | |
| +0.38% | -1.78% | +29.95% | +12.54% | 297B | |
| +0.60% | -1.32% | +21.49% | +61.52% | 204B | |
| +1.06% | +4.04% | -60.69% | -50.74% | 170B | |
| Average | -0.30% | -0.28% | +16.10% | +56.35% | 375.36B | |
| Weighted average by Cap. | -0.34% | -0.62% | +19.77% | +83.96% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 30.19B 25.96B 23.56B 22.59B 41.26B 2,783B 42.74B 277B 111B 1,327B 113B 111B 4,740B | 32.05B 27.56B 25.01B 23.98B 43.79B 2,954B 45.37B 294B 118B 1,409B 120B 118B 5,032B |
| Net income | 8.98B 7.72B 7.01B 6.72B 12.27B 828B 12.71B 82.3B 32.95B 395B 33.7B 32.98B 1,410B | 9.91B 8.52B 7.73B 7.42B 13.54B 914B 14.03B 90.85B 36.38B 436B 37.2B 36.4B 1,556B |
| Net Debt | 4.61B 3.96B 3.6B 3.45B 6.3B 425B 6.53B 42.27B 16.92B 203B 17.31B 16.94B 724B | -3.1B -2.66B -2.42B -2.32B -4.24B -286B -4.39B -28.41B -11.38B -136B -11.63B -11.38B -487B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 04/03/26 | 148.22 $ | +0.26% | 6,925,216 |
| 03/03/26 | 147.83 $ | -1.47% | 6,741,675 |
| 02/03/26 | 150.03 $ | +0.73% | 7,183,285 |
| 27/02/26 | 148.95 $ | +3.60% | 11,195,856 |
| 26/02/26 | 143.77 $ | -2.28% | 7,987,607 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- GILD Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition